Literature DB >> 7852523

Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases.

D F Swaab1, J S Purba, M A Hofman.   

Abstract

Animal experiments have shown that the parvocellular oxytocin (OXT) neurons of the hypothalamic paraventricular nucleus (PVN) inhibit food intake. In the present study, the PVN and its OXT neurons have been investigated in an extreme human eating disorder, i.e. the Prader-Willi syndrome (PWS). PWS patients are characterized by gross obesity, insatiable hunger, hypotonia, hypogonadism, and mental retardation. The PVN of 5 PWS patients (2 males and 3 females), varying in age between 22-64 yr, and 27 controls (14 males and 13 females) without any primary neurological or psychiatric diseases was morphometrically investigated after conventional staining with thionine and immunocytochemical staining for OXT and vasopressin (AVP). The thionine-stained volume of the PVN was 28% smaller in PWS patients (P = 0.028), and the total cell number was 38% lower (P = 0.009). The immunoreactivity for OXT and AVP was decreased in PWS patients, although the variability within the groups was high. A strong and highly significant decrease (42%; P = 0.016) was found in the number of OXT-expressing neurons of the PWS patients. The volume of the PVN-containing OXT-expressing neurons decreased by 54% (P = 0.028) in PWS. The number of AVP-expressing neurons in the PVN did not change significantly. The OXT neurons of the PVN seem to be good candidates for playing a physiological role in ingestive behavior as "satiety neurons" in the human hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852523     DOI: 10.1210/jcem.80.2.7852523

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  110 in total

Review 1.  Genetic approaches to understanding human obesity.

Authors:  Shwetha Ramachandrappa; I Sadaf Farooqi
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 3.  Developmental specification of metabolic circuitry.

Authors:  Amanda E Elson; Richard B Simerly
Journal:  Front Neuroendocrinol       Date:  2015-09-25       Impact factor: 8.606

4.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

5.  Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.

Authors:  Gregory J Morton; Brendan S Thatcher; Roger D Reidelberger; Kayoko Ogimoto; Tami Wolden-Hanson; Denis G Baskin; Michael W Schwartz; James E Blevins
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-18       Impact factor: 4.310

Review 6.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 7.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

Review 8.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

Review 9.  Development of the human hypothalamus.

Authors:  D F Swaab
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

10.  Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice.

Authors:  Bassil M Kublaoui; Terry Gemelli; Kristen P Tolson; Yu Wang; Andrew R Zinn
Journal:  Mol Endocrinol       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.